The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | TGEN TECOGEN INC. | Stephen Lafaille VP of Business Development | XIn-the-money exercise Stock Options (Right to Buy)derivative | -25,000 | $1.10 | $28k | 27,500 | Jun 24, 2025 |
| Jun 23, 2025 | TGEN TECOGEN INC. | Stephen Lafaille VP of Business Development | XIn-the-money exercise Stock Options (Right to Buy)derivative | -10,000 | $1.10 | $11k | 17,500 | Jun 24, 2025 |
| Jun 20, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Common Stock | +1,000 | $16.00 | $16k | 129,916 | Jun 24, 2025 |
| Jun 20, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Common Stock | +7,600 | $15.00 | $114k | 137,516 | Jun 24, 2025 |
| Jun 20, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -10 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -76 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | OTRK Ontrak, Inc. | Terren S Peizer owner | XIn-the-money exercise Common Stockindirect: By Humanitario | +500,000 | $0.00 | $700 | 2,305,480 | Jun 24, 2025 |
| Jun 20, 2025 | OTRK Ontrak, Inc. | Terren S Peizer owner | XIn-the-money exercise Pre-Funded Common Stock Purchase Warrantderivativeindirect: By Humanitario | -500,000 | $0.00 | $0 | 799,575 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Common Stockindirect: By ADAR1 Partners, LP | -100 | $60.00 | $6,000 | 4,392,637 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Common Stockindirect: By ADAR1 Partners, LP | -1,400 | $70.00 | $98k | 4,391,237 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Common Stockindirect: By Spearhead Insurance Solutions IDF, LLC | -200 | $70.00 | $14k | 743,358 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Put Option (right to sell)derivativeindirect: By ADAR1 Partners, LP | -1 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Put Option (right to sell)derivativeindirect: By ADAR1 Partners, LP | -14 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC owner | XIn-the-money exercise Put Option (right to sell)derivativeindirect: By Spearhead Insurance Solutions IDF, LLC | -2 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | - BlackRock Direct Lending Corp. | Institution for Social Security Public owner | XIn-the-money exercise Common Stock, $0.001 par value | +2,084,925 | $9.58 | $20M | 29,076,852 | Jun 24, 2025 |
| Jun 20, 2025 | - BlackRock Direct Lending Corp. | Institution for Social Security Public owner | XIn-the-money exercise Obligation to Buyderivative | -2,084,925 | - | - | 0 | Jun 24, 2025 |
| Jun 17, 2025 | STLN Oncology Institute, Inc. | Richard A Barasch director | XIn-the-money exercise Common Stockindirect: By LLC | +679,224 | $1.20 | $814k | 3,234,765 | Jun 24, 2025 |
| Jun 17, 2025 | STLN Oncology Institute, Inc. | Richard A Barasch director | XIn-the-money exercise Common Warrantderivativeindirect: By LLC | -679,224 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise Common Stockindirect: Held by Barnett Equity Holdings, LLC | +2,255,048 | - | - | 3,976,063 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise Common Stockindirect: Held by Sixth Street Specialty Lending, Inc. | +118,687 | - | - | 1,129,212 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise Common Stockindirect: Held by Barnett Equity Holdings, LLC | +1,711,113 | - | - | 5,687,176 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise Common Stockindirect: Held by Sixth Street Specialty Lending, Inc. | +90,059 | - | - | 1,219,271 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise 2018 Warrantsderivativeindirect: Held by Barnett Equity Holdings, LLC | -13,009,892 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise 2018 Warrantsderivativeindirect: Held by Sixth Street Specialty Lending, Inc. | -684,731 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise 2020 Warrantsderivativeindirect: Held by Barnett Equity Holdings, LLC | -10,829,823 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 20, 2025 | CAI Caris Life Sciences, Inc. | TSSP Sub-Fund HoldCo LLC other | XIn-the-money exercise 2020 Warrantsderivativeindirect: Held by Sixth Street Specialty Lending, Inc. | -569,991 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 16, 2025 | TGEN TECOGEN INC. | Robert A Panora COO and President | XIn-the-money exercise Common Stock | +12,723 | $0.79 | $10k | 82,723 | Jun 20, 2025 |
| Jun 16, 2025 | TGEN TECOGEN INC. | Robert A Panora COO and President | XIn-the-money exercise Common Stock | +30,000 | $0.71 | $21k | 112,723 | Jun 20, 2025 |
| Jun 16, 2025 | TGEN TECOGEN INC. | Robert A Panora COO and President | XIn-the-money exercise Common Stock | +52,500 | $1.10 | $58k | 165,223 | Jun 20, 2025 |
| Jun 19, 2025 | NONE. EBR Systems, Inc. | Bronwyn Evans director | XIn-the-money exercise Common Stockindirect: By Bronwyn Evans and Peter Douglas Gordon | +30,000 | $1.00 | $30k | 355,783 | Jun 20, 2025 |
| Jun 19, 2025 | NONE. EBR Systems, Inc. | Bronwyn Evans director | XIn-the-money exercise Subscription Rights (right to buy)derivativeindirect: By Bronwyn Evans and Peter Douglas Gordon | -30,000 | $0.00 | $0 | 0 | Jun 20, 2025 |
| Jun 12, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Common Stock | +1,000 | $15.00 | $15k | 123,516 | Jun 17, 2025 |
| Jun 13, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Common Stock | +5,400 | $15.00 | $81k | 128,916 | Jun 17, 2025 |
| Jun 12, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -10 | $0.00 | $0 | 13,000 | Jun 17, 2025 |
| Jun 13, 2025 | AEYE AUDIOEYE INC | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -54 | $0.00 | $0 | 7,600 | Jun 17, 2025 |
| Jun 9, 2025 | CBUS Cibus, Inc. | Rory B Riggs Chief Executive Officer | XIn-the-money exercise Class A Common Stock | +4,000,000 | $0.00 | $400 | 14,533,307 | Jun 11, 2025 |
| Jun 9, 2025 | CBUS Cibus, Inc. | Rory B Riggs Chief Executive Officer | XIn-the-money exercise Class A Common Stock | +50,000 | $0.01 | $500 | 14,583,307 | Jun 11, 2025 |
| Jun 9, 2025 | CBUS Cibus, Inc. | Rory B Riggs Chief Executive Officer | XIn-the-money exercise Pre-Funded Warrant (right to buy)derivative | -4,000,000 | $0.00 | $0 | 0 | Jun 11, 2025 |
| Jun 9, 2025 | CBUS Cibus, Inc. | Rory B Riggs Chief Executive Officer | XIn-the-money exercise Pre-Funded Warrant (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Jun 11, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Ming-Fu (alan) Chiang director | XIn-the-money exercise Common Stockindirect: By HCWG LLC | +117,188 | $12.00 | $1.4M | 441,876 | Jun 5, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Ming-Fu (alan) Chiang director | XIn-the-money exercise Warrant (right to buy)derivativeindirect: By HCWG LLC | -117,188 | $0.00 | $0 | 0 | Jun 5, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Patrick Walters COO | XIn-the-money exercise Common Stockindirect: By HCWG LLC | +24,063 | $12.00 | $289k | 90,732 | Jun 5, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Patrick Walters COO | XIn-the-money exercise Warrant (right to buy)derivativeindirect: By HCWG LLC | -24,063 | $0.00 | $0 | 0 | Jun 5, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Keithly Garnett CFO | XIn-the-money exercise Common Stockindirect: By The Hilkiah Group LLC | +13,438 | $12.00 | $161k | 50,669 | Jun 5, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Keithly Garnett CFO | XIn-the-money exercise Warrant (right to buy)derivativeindirect: By The Hilkiah Group LLC | -13,438 | $0.00 | $0 | 0 | Jun 5, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Amir F Heshmatpour President | XIn-the-money exercise Common Stockindirect: By HCWG LLC | +78,125 | $12.00 | $938k | 294,584 | Jun 5, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Amir F Heshmatpour President | XIn-the-money exercise Warrant (right to buy)derivativeindirect: By HCWG LLC | -78,125 | $0.00 | $0 | 0 | Jun 5, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Thomas C Chen CEO | XIn-the-money exercise Common Stockindirect: By HCWG LLC | +79,688 | $12.00 | $956k | 300,475 | Jun 5, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Thomas C Chen CEO | XIn-the-money exercise Warrant (right to buy)derivativeindirect: By HCWG | -79,688 | $0.00 | $0 | 0 | Jun 5, 2025 |
| Jun 2, 2025 | JETMF Global Crossing Airlines Group Inc. | Ryan Goepel See Remarks | XIn-the-money exercise Common Stock10b5-1 | +71,667 | $0.25 | $18k | 1,713,224 | Jun 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.